Portfolio — 4 May 2026

Minister for Health and Ageing Mark Butler made cancer treatment access the centrepiece of his 4 May activity, announcing that Carvykti — a CAR-T cell therapy for multiple myeloma — will be provided free to patients in public hospitals under the hospital funding agreement, jointly funded by the Albanese Government and state governments [TA-260505-health-e29de5950d24].

The treatment is immediately available at the Alfred Hospital and Peter MacCallum Cancer Centre, with a staged rollout to specialist public hospitals in other states to follow [TA-260505-health-bc1aa8d519f0]. This announcement extends a pattern visible across the Health portfolio's recent activity: using a combination of PBS listings, hospital agreements, and Commonwealth-state cost-sharing to bring high-cost cancer therapies within reach of patients who would otherwise face significant out-of-pocket costs.

The Carvykti decision follows the February 28 expansion of PBS listings for the immunotherapies Opdivo and Yervoy, indicating a sustained push to widen access to innovative oncology treatments rather than a one-off policy moment.

The day also captured a cross-portfolio signal: in a media interview Butler referenced the government's five-percent deposit assistance scheme, noting it has already helped around 300,000 young Australians enter the housing market [TA-260505-health-bb192889533d]. Butler holds portfolios spanning Health and Ageing alongside Disability and the NDIS, and the housing reference — outside his ministerial responsibilities — suggests broader government-message amplification rather than a portfolio-specific announcement.

No parliamentary record is available for 4 May; the activity window reflects media release and media interview material only.